The impact of Oncotype DX testing on adjuvant chemotherapy decision making in 1-3 node positive breast cancer.

Malam, Yogeshkumar; Rabie, Mohamed; Geropantas, Konstantinos; Alexander, Susanna; Pain, Simon; Youssef, Mina

Malam, Yogeshkumar; Rabie, Mohamed; Geropantas, Konstantinos; Alexander, Susanna; Pain, Simon; Youssef, Mina.

Afiliación

Malam Y; Department of Breast Surgery, Norfolk and Norwich University Hospital Trust, Norwich, UK.
Rabie M; Department of Breast Surgery, Norfolk and Norwich University Hospital Trust, Norwich, UK.
Geropantas K; Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Alexander S; Department of Oncology, Norfolk and Norwich University Hospital Trust, Norwich, UK.
Pain S; Department of Oncology, Norfolk and Norwich University Hospital Trust, Norwich, UK.
Youssef M; Department of Breast Surgery, Norfolk and Norwich University Hospital Trust, Norwich, UK.

Cancer Rep (Hoboken) ; 5(8): e1546, 2022 08.

Article en En | MEDLINE | ID: mdl-34664429

Asunto(s)

Neoplasias de la Mama; Neoplasias de la Mama/diagnóstico; Neoplasias de la Mama/tratamiento farmacológico; Neoplasias de la Mama/genética; Quimioterapia Adyuvante; Toma de Decisiones; Femenino; Humanos; Receptores de Estrógenos/metabolismo; Receptores de Estrógenos/uso terapéutico; Estudios Retrospectivos

Palabras clave

Oncotype DX; adjuvant chemotherapy; breast cancer; gene based assay; node positive

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Cancer Rep (Hoboken) Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google